-
1
-
-
84875255442
-
Bile acids in the colon, from healthy to cytotoxic molecules
-
Barrasa JI, Olmo N, Lizarbe MA, Turnay J. Bile acids in the colon, from healthy to cytotoxic molecules. Toxicol In Vitro 2013; 27:964-77
-
(2013)
Toxicol In Vitro
, vol.27
, pp. 964-977
-
-
Barrasa, J.I.1
Olmo, N.2
Lizarbe, M.A.3
Turnay, J.4
-
2
-
-
66349134159
-
Fifty years of advances in bile acid synthesis and metabolism
-
Russell DW. Fifty years of advances in bile acid synthesis and metabolism. J Lipid Res 2009;50:S120-5
-
(2009)
J Lipid Res
, vol.50
-
-
Russell, D.W.1
-
3
-
-
33751518532
-
Pharmacology of bile acids and their derivatives: Absorption promoters and therapeutic agents
-
Mikov M, Fawcett JP, Kuhajda K, Kevresan S. Pharmacology of bile acids and their derivatives: Absorption promoters and therapeutic agents. Eur J Drug Metab Pharmacokinet 2006;31:237-51
-
(2006)
Eur J Drug Metab Pharmacokinet
, vol.31
, pp. 237-251
-
-
Mikov, M.1
Fawcett, J.P.2
Kuhajda, K.3
Kevresan, S.4
-
4
-
-
85044693973
-
The impact of farnesoid X receptor activation on intestinal permeability in inflammatory bowel disease
-
Stojancevic M, Stankov K, Mikov M. The impact of farnesoid X receptor activation on intestinal permeability in inflammatory bowel disease. Can J Gastroenterol 2012;6:631-7
-
(2012)
Can J Gastroenterol
, vol.6
, pp. 631-637
-
-
Stojancevic, M.1
Stankov, K.2
Mikov, M.3
-
5
-
-
84865540426
-
Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bileacid synthesis in mice
-
Kong B, Wang L, Chiang JY, et al. Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bileacid synthesis in mice. Hepatology 2012;56:1034-43
-
(2012)
Hepatology
, vol.56
, pp. 1034-1043
-
-
Kong, B.1
Wang, L.2
Chiang, J.Y.3
-
8
-
-
78650788593
-
The mammalian orphan nuclear receptors: Orphans as cellular guardians
-
Ranhotra HS. The mammalian orphan nuclear receptors: Orphans as cellular guardians. J Recept Signal Transduct Res 2011;31:20-5
-
(2011)
J Recept Signal Transduct Res
, vol.31
, pp. 20-25
-
-
Ranhotra, H.S.1
-
9
-
-
33751516329
-
International union of pharmacology LXII The NR1H and NR1I receptors: Constitutive androstane receptor, pregnene X receptor, farnesoid X receptor alpha, farnesoid X receptor beta, liver X receptor alpha, liver X receptor beta, and vitamin D receptor
-
Moore DD, Kato S, Xie W, et al. International Union of Pharmacology. LXII. The NR1H and NR1I receptors: Constitutive androstane receptor, pregnene X receptor, farnesoid X receptor alpha, farnesoid X receptor beta, liver X receptor alpha, liver X receptor beta, and vitamin D receptor. Pharmacol Rev 2006;58: 742-59
-
(2006)
Pharmacol Rev
, vol.58
, pp. 742-759
-
-
Moore, D.D.1
Kato, S.2
Xie, W.3
-
10
-
-
0003269455
-
A G protein-coupled receptor responsive to bile acids
-
Kawamata Y, Fujii R, Hosoya M, et al. A G protein-coupled receptor responsive to bile acids. J Biol Chem 2003;278:9435-40
-
(2003)
J Biol Chem
, vol.278
, pp. 9435-9440
-
-
Kawamata, Y.1
Fujii, R.2
Hosoya, M.3
-
11
-
-
0043202882
-
Activation of muscarinic receptor signaling by bile acids: Physiological and medical implications
-
Raufman JP, Cheng K, Zimniak P. Activation of muscarinic receptor signaling by bile acids: Physiological and medical implications. Dig Dis Sci 2003;48:1431-44
-
(2003)
Dig Dis Sci
, vol.48
, pp. 1431-1444
-
-
Raufman, J.P.1
Cheng, K.2
Zimniak, P.3
-
13
-
-
79959525960
-
The bile acid membrane receptor TGR5: A valuable metabolic target
-
Pols TW, Noriega LG, Nomura M, et al. The bile acid membrane receptor TGR5: A valuable metabolic target. Dig Dis 2011;29: 37-44
-
(2011)
Dig Dis
, vol.29
, pp. 37-44
-
-
Pols, T.W.1
Noriega, L.G.2
Nomura, M.3
-
14
-
-
58249110568
-
Role of bile acids and bile acid receptors in metabolic regulation
-
Lefebvre P, Cariou B, Lien F, et al. Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev 2009;89:147-91
-
(2009)
Physiol Rev
, vol.89
, pp. 147-191
-
-
Lefebvre, P.1
Cariou, B.2
Lien, F.3
-
15
-
-
70350292362
-
Bile-Acidactivated receptors: Targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders
-
Fiorucci S, Mencarelli A, Palladino G, Cipriani S. Bile-Acidactivated receptors: Targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders. Trends Pharmacol Sci 2009;30:570-80
-
(2009)
Trends Pharmacol Sci
, vol.30
, pp. 570-580
-
-
Fiorucci, S.1
Mencarelli, A.2
Palladino, G.3
Cipriani, S.4
-
17
-
-
84868360297
-
Perspective: TGR5 (Gpbar-1) in liver physiology and disease
-
Keitel V, Häussinger D. Perspective: TGR5 (Gpbar-1) in liver physiology and disease. Clin Res Hepatol Gastroenterol 2012;36: 412-9
-
(2012)
Clin Res Hepatol Gastroenterol
, vol.36
, pp. 412-419
-
-
Keitel, V.1
Häussinger, D.2
-
18
-
-
78649386642
-
The bile acid receptor TGR5 (Gpbar-1) acts as a neurosteroid receptor in brain
-
Keitel V, Görg B, Bidmon HJ, et al. The bile acid receptor TGR5 (Gpbar-1) acts as a neurosteroid receptor in brain. Glia 2010;58: 1794-805
-
(2010)
Glia
, vol.58
, pp. 1794-1805
-
-
Keitel, V.1
Görg, B.2
Bidmon, H.J.3
-
19
-
-
80052220468
-
Advances in bile acid medicinal chemistry
-
Sharma R, Long A, Gilmer JF. Advances in bile acid medicinal chemistry. Curr Med Chem 2011;18:4029-52
-
(2011)
Curr Med Chem
, vol.18
, pp. 4029-4052
-
-
Sharma, R.1
Long, A.2
Gilmer, J.F.3
-
21
-
-
84867574634
-
Review article: The emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-Alcoholic fatty liver disease
-
Zarrinpar A, Loomba R. Review article: The emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-Alcoholic fatty liver disease. Aliment Pharmacol Ther 2012;36:909-21
-
(2012)
Aliment Pharmacol Ther
, vol.36
, pp. 909-921
-
-
Zarrinpar, A.1
Loomba, R.2
-
22
-
-
84857932052
-
Role of microRNAs in diabetes and its cardiovascular complications
-
Shantikumar S, Caporali A, Emanueli C. Role of microRNAs in diabetes and its cardiovascular complications. Cardiovasc Res 2012;93:583-93
-
(2012)
Cardiovasc Res
, vol.93
, pp. 583-593
-
-
Shantikumar, S.1
Caporali, A.2
Emanueli, C.3
-
23
-
-
34248223285
-
Biology of incretins: GLP-1 and GIP
-
Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology 2007;132:2131-57
-
(2007)
Gastroenterology
, vol.132
, pp. 2131-2157
-
-
Baggio, L.L.1
Drucker, D.J.2
-
24
-
-
67651173077
-
Incretin-based therapies for type 2 diabetes mellitus
-
Lovshin JA, Drucker DJ. Incretin-based therapies for type 2 diabetes mellitus. Nat Rev Endocrinol 2009;5:262-9
-
(2009)
Nat Rev Endocrinol
, vol.5
, pp. 262-269
-
-
Lovshin, J.A.1
Drucker, D.J.2
-
25
-
-
77952315531
-
Addition of incretin therapy to metformin in type 2 diabetes
-
Scheen AJ, Radermecker RP. Addition of incretin therapy to metformin in type 2 diabetes. The Lancet 2010;375:1410-12
-
(2010)
Lancet
, vol.375
, pp. 1410-1412
-
-
Scheen, A.J.1
Radermecker, R.P.2
-
26
-
-
33644618433
-
The biology of incretin hormones
-
Drucker DJ. The biology of incretin hormones. Cell Metab 2006;3: 153-65
-
(2006)
Cell Metab
, vol.3
, pp. 153-165
-
-
Drucker, D.J.1
-
27
-
-
13844299425
-
Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1
-
Katsuma S, Hirasawa A, Tsujimoto G Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem Biophys Res Commun 2005;329:386-90
-
(2005)
Biochem Biophys Res Commun
, vol.329
, pp. 386-390
-
-
Katsuma, S.1
Hirasawa, A.2
Tsujimoto, G.3
-
28
-
-
69149083245
-
TGR5-mediated bile acid sensing controls glucose homeostasis
-
Thomas C, Gioiello A, Noriega L, et al. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab 2009;10: 167-77
-
(2009)
Cell Metab
, vol.10
, pp. 167-177
-
-
Thomas, C.1
Gioiello, A.2
Noriega, L.3
-
29
-
-
39449124119
-
Bile acids and the membrane bile acid receptor TGR5-connecting nutrition and metabolism
-
Thomas C, Auwerx J, Schoonjans K. Bile acids and the membrane bile acid receptor TGR5-connecting nutrition and metabolism. Thyroid 2008;18:167-74
-
(2008)
Thyroid
, vol.18
, pp. 167-174
-
-
Thomas, C.1
Auwerx, J.2
Schoonjans, K.3
-
30
-
-
84861682490
-
TGR5 potentiates GLP-1 secretion in response to anionic exchange resins
-
Harach T, Pols TW, Nomura M, et al. TGR5 potentiates GLP-1 secretion in response to anionic exchange resins. Sci Rep 2012; 2:430
-
(2012)
Sci Rep
, vol.2
, pp. 430
-
-
Harach, T.1
Pols, T.W.2
Nomura, M.3
-
31
-
-
77956399106
-
GLP-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N-And L-Type Ca2 channel-dependent exocytosis
-
De Marinis YZ, Salehi A, Ward CE, et al. GLP-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N-And L-Type Ca2 channel-dependent exocytosis. Cell Metab 2010;11:543-53
-
(2010)
Cell Metab
, vol.11
, pp. 543-553
-
-
De Marinis, Y.Z.1
Salehi, A.2
Ward, C.E.3
-
32
-
-
77953403465
-
Bile-induced secretion of glucagon-like peptide-1 pathophysiological implications in type 2 diabetes?
-
Knop FK. Bile-induced secretion of glucagon-like peptide-1: Pathophysiological implications in type 2 diabetes? Am J Physiol Endocrinol Metab 2010;299:E10-13
-
(2010)
Am J Physiol Endocrinol Metab
, vol.299
-
-
Knop, F.K.1
-
33
-
-
79961165599
-
Current and future drug targets in weight management
-
Witkamp RF. Current and Future Drug Targets in Weight Management. Pharm Res 2011;28:1792-818
-
(2011)
Pharm Res
, vol.28
, pp. 1792-1818
-
-
Witkamp, R.F.1
-
34
-
-
34447568475
-
Incretin-based therapies: Mimetics versus protease inhibitors
-
Brubaker PL. Incretin-based therapies: Mimetics versus protease inhibitors. Trends Endocrinol Metab 2007;18:240-5
-
(2007)
Trends Endocrinol Metab
, vol.18
, pp. 240-245
-
-
Brubaker, P.L.1
-
35
-
-
77953962428
-
Targeting the TGR5-GLP-1 pathway to combat type 2 diabetes and non-Alcoholic fatty liver disease
-
Pols TW, Auwerx J, Schoonjans K. Targeting the TGR5-GLP-1 pathway to combat type 2 diabetes and non-Alcoholic fatty liver disease. Gastroenterol Clin Biol 2010;34:270-3
-
(2010)
Gastroenterol Clin Biol
, vol.34
, pp. 270-273
-
-
Pols, T.W.1
Auwerx, J.2
Schoonjans, K.3
-
36
-
-
79956088562
-
The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation
-
Pols TW, Noriega LG, Nomura M, et al. The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation. J Hepatol 2011;54:1263-72
-
(2011)
J Hepatol
, vol.54
, pp. 1263-1272
-
-
Pols, T.W.1
Noriega, L.G.2
Nomura, M.3
-
37
-
-
31444454037
-
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
-
Watanabe M, Houten SM, Mataki C, et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 2006;439:484-9
-
(2006)
Nature
, vol.439
, pp. 484-489
-
-
Watanabe, M.1
Houten, S.M.2
Mataki, C.3
-
38
-
-
76549086983
-
Bile acid-Activated receptors in the treatment of dyslipidemia and related disorders
-
Fiorucci S, Cipriani S, Baldelli F, Mencarelli A. Bile acid-Activated receptors in the treatment of dyslipidemia and related disorders. Prog Lipid Res 2010;49:171-85
-
(2010)
Prog Lipid Res
, vol.49
, pp. 171-185
-
-
Fiorucci, S.1
Cipriani, S.2
Baldelli, F.3
Mencarelli, A.4
-
39
-
-
33751066787
-
Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice
-
Maruyama T, Tanaka K, Suzuki J, et al. Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice. J Endocrinol 2006;191:197-205
-
(2006)
J Endocrinol
, vol.191
, pp. 197-205
-
-
Maruyama, T.1
Tanaka, K.2
Suzuki, J.3
-
40
-
-
77952562273
-
Gender-dependent effect of Gpbar1 genetic deletion on the metabolic profiles of diet-induced obese mice
-
Vassileva G, Hu W, Hoos L, et al. Gender-dependent effect of Gpbar1 genetic deletion on the metabolic profiles of diet-induced obese mice. J Endocrinol 2010;205:225-32
-
(2010)
J Endocrinol
, vol.205
, pp. 225-232
-
-
Vassileva, G.1
Hu, W.2
Hoos, L.3
-
41
-
-
77956455354
-
Plasma bile acids are not associated with energy metabolism in humans
-
Brufau G, Bahr MJ, Staels B, et al. Plasma bile acids are not associated with energy metabolism in humans. Nutr Metab (Lond) 2010;7:73
-
(2010)
Nutr Metab (Lond
, vol.7
, pp. 73
-
-
Brufau, G.1
Bahr, M.J.2
Staels, B.3
-
42
-
-
84867867477
-
The nuclear factor kappa B signaling pathway: Integrating metabolism with inflammation
-
Tornatore L, Thotakura AK, Bennett J, et al. The nuclear factor kappa B signaling pathway: Integrating metabolism with inflammation. Trends Cell Biol 2012;22:557-66
-
(2012)
Trends Cell Biol
, vol.22
, pp. 557-566
-
-
Tornatore, L.1
Thotakura, A.K.2
Bennett, J.3
-
43
-
-
77951918926
-
Macrophages, inflammation, and insulin resistance
-
Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 2010;72:219-46
-
(2010)
Annu Rev Physiol
, vol.72
, pp. 219-246
-
-
Olefsky, J.M.1
Glass, C.K.2
-
44
-
-
4644324186
-
NF-kappaB functions as a tumour promoter in inflammation-Associated cancer
-
Pikarsky E, Porat RM, Stein I, et al. NF-kappaB functions as a tumour promoter in inflammation-Associated cancer. Nature 2004; 431:461-6
-
(2004)
Nature
, vol.431
, pp. 461-466
-
-
Pikarsky, E.1
Porat, R.M.2
Stein, I.3
-
45
-
-
77349087078
-
SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity
-
Yoshizaki T, Schenk S, Imamura T, et al. SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity. Am J Physiol Endocrinol Metab 2010;298: E419-28
-
(2010)
Am J Physiol Endocrinol Metab
, vol.298
-
-
Yoshizaki, T.1
Schenk, S.2
Imamura, T.3
-
46
-
-
0026657890
-
Differential effects of chenodeoxycholic and ursodeoxycholic acids on interleukin 1, interleukin 6 and tumor necrosis factor-Alpha production by monocytes
-
Calmus Y, Guechot J, Podevin P, et al. Differential effects of chenodeoxycholic and ursodeoxycholic acids on interleukin 1, interleukin 6 and tumor necrosis factor-Alpha production by monocytes. Hepatology 1992;16:719-23
-
(1992)
Hepatology
, vol.16
, pp. 719-723
-
-
Calmus, Y.1
Guechot, J.2
Podevin, P.3
-
47
-
-
44649092024
-
Expression and function of the bile acid receptor TGR5 in Kupffer cells
-
Keitel V, Donner M, Winandy S, et al. Expression and function of the bile acid receptor TGR5 in Kupffer cells. Biochem Biophys Res Commun 2008;372:78-84
-
(2008)
Biochem Biophys Res Commun
, vol.372
, pp. 78-84
-
-
Keitel, V.1
Donner, M.2
Winandy, S.3
-
48
-
-
84864861866
-
Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease
-
Porez G, Prawitt J, Gross B, Staels B. Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease. J Lipid Res 2012;53:1723-37
-
(2012)
J Lipid Res
, vol.53
, pp. 1723-1737
-
-
Porez, G.1
Prawitt, J.2
Gross, B.3
Staels, B.4
-
49
-
-
84864133462
-
Cellular and molecular players in the atherosclerotic plaque progression
-
Businaro R, Tagliani A, Buttari B, et al. Cellular and molecular players in the atherosclerotic plaque progression. Ann N YAcad Sci 2012;1262:134-41
-
(2012)
Ann N YAcad Sci
, vol.1262
, pp. 134-141
-
-
Businaro, R.1
Tagliani, A.2
Buttari, B.3
-
50
-
-
75749148425
-
Inflammation in atherosclerosis: Transition from theory to practice
-
Libby P, Okamoto Y, Rocha VZ, Folco E. Inflammation in atherosclerosis: Transition from theory to practice. Circ J 2010;74: 213-20
-
(2010)
Circ J
, vol.74
, pp. 213-220
-
-
Libby, P.1
Okamoto, Y.2
Rocha, V.Z.3
Folco, E.4
-
52
-
-
69249205739
-
Obesity, inflammation, and atherosclerosis
-
Rocha VZ, Libby P. Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol 2009;6:399-409
-
(2009)
Nat Rev Cardiol
, vol.6
, pp. 399-409
-
-
Rocha, V.Z.1
Libby, P.2
-
53
-
-
82955168360
-
TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading
-
Pols TWH, Nomura M, Harach T, et al. TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading. Cell Metab 2011;14:747-57
-
(2011)
Cell Metab
, vol.14
, pp. 747-757
-
-
Pols, T.W.H.1
Nomura, M.2
Harach, T.3
-
54
-
-
0030949830
-
Inhibition of tumor necrosis factor-Alpha and interleukin-1-beta production by beta-Adrenoreceptor agonists from lipopolysaccharide-stimulated human peripheral blood mononuclear cells
-
Yoshimura T, Kurita C, Nagao T, et al. Inhibition of tumor necrosis factor-Alpha and interleukin-1-beta production by beta-Adrenoreceptor agonists from lipopolysaccharide-stimulated human peripheral blood mononuclear cells. Pharmacology 1997;54:144-52
-
(1997)
Pharmacology
, vol.54
, pp. 144-152
-
-
Yoshimura, T.1
Kurita, C.2
Nagao, T.3
-
55
-
-
78650878363
-
NF-kB, inflammation, and metabolic disease
-
Baker RG, Hayden MS, Ghosh S. NF-kB, inflammation, and metabolic disease. Cell Metab 2011;13:11-22
-
(2011)
Cell Metab
, vol.13
, pp. 11-22
-
-
Baker, R.G.1
Hayden, M.S.2
Ghosh, S.3
-
56
-
-
4544342570
-
Nuclear factor-kappaB: The enemy within
-
Aggarwal BB. Nuclear factor-kappaB: The enemy within. Cancer Cell 2004;6:203-8
-
(2004)
Cancer Cell
, vol.6
, pp. 203-208
-
-
Aggarwal, B.B.1
-
57
-
-
80053308007
-
The g-protein-coupled bile acid receptor gpbar1 (tgr5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor k light-chain enhancer of activated b cells (nf-kb) in mice
-
Wang YD, Chen WD, Yu D, et al. The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor k light-chain enhancer of activated B cells (NF-kB) in mice. Hepatology 2011; 54:1421-32
-
(2011)
Hepatology
, vol.54
, pp. 1421-1432
-
-
Wang, Y.D.1
Chen, W.D.2
Yu, D.3
-
58
-
-
34248209613
-
Macrophage-specific inhibition of NF-kappaB activation reduces foam cell formation
-
Ferreira V, van Dijk KW, Groen AK, et al. Macrophage-specific inhibition of NF-kappaB activation reduces foam cell formation. Atherosclerosis 2007;192:283-90
-
(2007)
Atherosclerosis
, vol.192
, pp. 283-290
-
-
Ferreira, V.1
Van Dijk, K.W.2
Groen, A.K.3
-
59
-
-
80055090450
-
The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis
-
Cipriani S, Mencarelli A, Chini MG, et al. The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis. PLoS One 2011;6: E25637
-
(2011)
PLoS One
, vol.6
-
-
Cipriani, S.1
Mencarelli, A.2
Chini, M.G.3
-
60
-
-
0030036174
-
Biliary decompression promotes Kupffer cell recovery in obstructive jaundice
-
Clements WD, McCaigue M, Erwin P, et al. Biliary decompression promotes Kupffer cell recovery in obstructive jaundice. Gut 1996; 38:925-31
-
(1996)
Gut
, vol.38
, pp. 925-931
-
-
Clements, W.D.1
McCaigue, M.2
Erwin, P.3
-
61
-
-
67349205002
-
Kupffer cells in non-Alcoholic fatty liver disease: The emerging view
-
Baffy G. Kupffer cells in non-Alcoholic fatty liver disease: The emerging view. J Hepatol 2009;51:212-23
-
(2009)
J Hepatol
, vol.51
, pp. 212-223
-
-
Baffy, G.1
-
62
-
-
0033053956
-
Reversible Kupffer cell suppression in biliary obstruction is caused by hydrophobic bile acids
-
Sung JJ, Go MY. Reversible Kupffer cell suppression in biliary obstruction is caused by hydrophobic bile acids. J Hepatol 1999;30: 413-8
-
(1999)
J Hepatol
, vol.30
, pp. 413-418
-
-
Sung, J.J.1
Go, M.Y.2
-
63
-
-
0025304385
-
The role of bile acids in the development of endotoxemia during obstructive jaundice in the rat
-
Van Bossuyt H, Desmaretz C, Gaeta GB, Wisse E. The role of bile acids in the development of endotoxemia during obstructive jaundice in the rat. J Hepatol 1990;10:274-9
-
(1990)
J Hepatol
, vol.10
, pp. 274-279
-
-
Van Bossuyt, H.1
Desmaretz, C.2
Gaeta, G.B.3
Wisse, E.4
-
64
-
-
0027768854
-
Impaired bacterial killing in early obstructive jaundice
-
Scott-Conner CE, Grogan JB, Scher KS, et al. Impaired bacterial killing in early obstructive jaundice. Am J Surg 1993;166:308-10
-
(1993)
Am J Surg
, vol.166
, pp. 308-310
-
-
Scott-Conner, C.E.1
Grogan, J.B.2
Scher, K.S.3
-
65
-
-
0025138309
-
Obstructive jaundice promotes bacterial translocation from the gut
-
Deitch EA, Sittig K, Li M, et al. Obstructive jaundice promotes bacterial translocation from the gut. Am J Surg 1990;159: 79-84
-
(1990)
Am J Surg
, vol.159
, pp. 79-84
-
-
Deitch, E.A.1
Sittig, K.2
Li, M.3
-
66
-
-
25844459154
-
Nf-Kappa B linking inflammation and immunity to cancer development and progression
-
Karin M, Greten FR. NF-kappa B; linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005;5:749-59
-
(2005)
Nat Rev Immunol
, vol.5
, pp. 749-759
-
-
Karin, M.1
Greten, F.R.2
-
67
-
-
33947383769
-
The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells
-
Keitel V, Reinehr R, Gatsios P, et al. The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells. Hepatology 2007;45:695-704
-
(2007)
Hepatology
, vol.45
, pp. 695-704
-
-
Keitel, V.1
Reinehr, R.2
Gatsios, P.3
-
68
-
-
77957756211
-
Pathogenesis of the hyperlipidemia of Gram-negative bacterial sepsis may involve pathomorphological changes in liver sinusoidal endothelial cells
-
Cheluvappa R, Denning GM, Lau GW, et al. Pathogenesis of the hyperlipidemia of Gram-negative bacterial sepsis may involve pathomorphological changes in liver sinusoidal endothelial cells. Int J Infect Dis 2010;14:e857-67
-
(2010)
Int J Infect Dis
, vol.14
-
-
Cheluvappa, R.1
Denning, G.M.2
Lau, G.W.3
-
69
-
-
27544516123
-
Scavenger receptors on sinusoidal liver endothelial cells are involved in the uptake of aldehyde-modified proteins
-
Duryee MJ, Freeman TL, Willis MS, et al. Scavenger receptors on sinusoidal liver endothelial cells are involved in the uptake of aldehyde-modified proteins. Mol Pharmacol 2005;68:1423-30
-
(2005)
Mol Pharmacol
, vol.68
, pp. 1423-1430
-
-
Duryee, M.J.1
Freeman, T.L.2
Willis, M.S.3
-
70
-
-
0345714699
-
Control of immune responses by scavenger liver endothelial cells
-
Knolle PA, Limmer A. Control of immune responses by scavenger liver endothelial cells. Swiss Med Wkly 2003;133:501-6
-
(2003)
Swiss Med Wkly
, vol.133
, pp. 501-506
-
-
Knolle, P.A.1
Limmer, A.2
-
71
-
-
17844403220
-
Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis
-
Keitel V, Burdelski M, Warskulat U, et al. Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis. Hepatology 2005;41:1160-72
-
(2005)
Hepatology
, vol.41
, pp. 1160-1172
-
-
Keitel, V.1
Burdelski, M.2
Warskulat, U.3
-
72
-
-
0347361545
-
Inhibition of bile salt-induced apoptosis by cyclic AMP involves serine/threonine phosphorylation of CD95
-
Reinehr R, Häussinger D Inhibition of bile salt-induced apoptosis by cyclic AMP involves serine/threonine phosphorylation of CD95. Gastroenterology 2004;126:249-62
-
(2004)
Gastroenterology
, vol.126
, pp. 249-262
-
-
Reinehr, R.1
Häussinger, D.2
-
73
-
-
84856081407
-
CD95 death receptor and epidermal growth factor receptor (EGFR) in liver cell apoptosis and regeneration
-
Reinehr R, Häussinger D. CD95 death receptor and epidermal growth factor receptor (EGFR) in liver cell apoptosis and regeneration. Arch Biochem Biophys 2012;518:2-7
-
(2012)
Arch Biochem Biophys
, vol.518
, pp. 2-7
-
-
Reinehr, R.1
Häussinger, D.2
-
74
-
-
0037621928
-
The role of nitric oxide synthase isoforms in extrahepatic portal hypertension: Studies in gene-knockout mice
-
Theodorakis NG, Wang YN, Skill NJ, et al. The role of nitric oxide synthase isoforms in extrahepatic portal hypertension: Studies in gene-knockout mice. Gastroenterology 2003;124:1500-8
-
(2003)
Gastroenterology
, vol.124
, pp. 1500-1508
-
-
Theodorakis, N.G.1
Wang, Y.N.2
Skill, N.J.3
-
75
-
-
35848962696
-
The molecules: Mechanisms of arterial vasodilatation observed in the splanchnic and systemic circulation in portal hypertension
-
Iwakiri Y. The molecules: Mechanisms of arterial vasodilatation observed in the splanchnic and systemic circulation in portal hypertension. J Clin Gastroenterol 2007;41:S288-94
-
(2007)
J Clin Gastroenterol
, vol.41
-
-
Iwakiri, Y.1
-
76
-
-
70349733124
-
Role of endothelial nitric oxide synthase in the development of portal hypertension in the carbon tetrachloride-induced liver fibrosis model
-
Theodorakis NG, Wang YN, Wu JM, et al. Role of endothelial nitric oxide synthase in the development of portal hypertension in the carbon tetrachloride-induced liver fibrosis model. Am J Physiol Gastrointest Liver Physiol 2009;297:G792-9
-
(2009)
Am J Physiol Gastrointest Liver Physiol
, vol.297
-
-
Theodorakis, N.G.1
Wang, Y.N.2
Wu, J.M.3
-
77
-
-
79961183211
-
Identification of circulatory and excretory metabolites of a novel nitric oxide donor ZJM-289 in rat plasma, bile, urine and faeces by liquid chromatography-Tandem mass spectrometry
-
Li N, Wang X, Li T, et al. Identification of circulatory and excretory metabolites of a novel nitric oxide donor ZJM-289 in rat plasma, bile, urine and faeces by liquid chromatography-Tandem mass spectrometry. Xenobiotica 2011;41:805-17
-
(2011)
Xenobiotica
, vol.41
, pp. 805-817
-
-
Li, N.1
Wang, X.2
Li, T.3
-
78
-
-
70349255713
-
The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders
-
Keitel V, Cupisti K, Ullmer C, et al. The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders. Hepatology 2009;50:861-70
-
(2009)
Hepatology
, vol.50
, pp. 861-870
-
-
Keitel, V.1
Cupisti, K.2
Ullmer, C.3
-
79
-
-
77954569180
-
The membrane-bound bile acid receptor TGR5 (Gpbar-1) is localized in the primary cilium of cholangiocytes
-
Keitel V, Ullmer C, Häussinger D. The membrane-bound bile acid receptor TGR5 (Gpbar-1) is localized in the primary cilium of cholangiocytes. Biol Chem 2010;391:785-9
-
(2010)
Biol Chem
, vol.391
, pp. 785-789
-
-
Keitel, V.1
Ullmer, C.2
Häussinger, D.3
-
80
-
-
79959503376
-
TGR5 in the biliary tree
-
Keitel V, Häussinger D. TGR5 in the biliary tree. Dig Dis 2011;29: 45-7
-
(2011)
Dig Dis
, vol.29
, pp. 45-47
-
-
Keitel, V.1
Häussinger, D.2
-
81
-
-
79957663467
-
The G protein-coupled bile acid receptor, TGR5, stimulates gallbladder filling
-
Li T, Holmstrom SR, Kir S, et al. The G protein-coupled bile acid receptor, TGR5, stimulates gallbladder filling. Mol Endocrinol 2011;25:1066-71
-
(2011)
Mol Endocrinol
, vol.25
, pp. 1066-1071
-
-
Li, T.1
Holmstrom, S.R.2
Kir, S.3
-
82
-
-
77956276608
-
Hydrophobic bile salts inhibit gallbladder smooth muscle function via stimulation of GPBAR1 receptors and activation of KATP channels
-
Lavoie B, Balemba OB, Godfrey C, et al. Hydrophobic bile salts inhibit gallbladder smooth muscle function via stimulation of GPBAR1 receptors and activation of KATP channels. J Physiol 2010;588:3295-305
-
(2010)
J Physiol
, vol.588
, pp. 3295-3305
-
-
Lavoie, B.1
Balemba, O.B.2
Godfrey, C.3
-
83
-
-
0037304208
-
Taurocholate feeding prevents CCl4-induced damage of large cholangiocytes through PI3-kinase-dependent mechanism
-
Marucci L, Alpini G, Glaser SS, et al. Taurocholate feeding prevents CCl4-induced damage of large cholangiocytes through PI3-kinase-dependent mechanism. Am J Physiol Gastrointest Liver Physiol 2003;284:G290-301
-
(2003)
Am J Physiol Gastrointest Liver Physiol
, vol.284
-
-
Marucci, L.1
Alpini, G.2
Glaser, S.S.3
-
84
-
-
34347381928
-
Taurocholic acid feeding prevents tumor necrosis factor-Alpha-induced damage of cholangiocytes by a PI3K-mediated pathway
-
Ueno Y, Francis H, Glaser S, et al. Taurocholic acid feeding prevents tumor necrosis factor-Alpha-induced damage of cholangiocytes by a PI3K-mediated pathway. Exp Biol Med (Maywood) 2007;232:942-9
-
(2007)
Exp Biol Med (Maywood
, vol.232
, pp. 942-949
-
-
Ueno, Y.1
Francis, H.2
Glaser, S.3
-
85
-
-
84868110731
-
Metabolic Syndrome and Risk of Cancer: A systematic review and meta-Analysis
-
Esposito K, Chiodini P, Colao A, et al. Metabolic Syndrome and Risk of Cancer: A systematic review and meta-Analysis. Diabetes Care 2012;35:2402-11
-
(2012)
Diabetes Care
, vol.35
, pp. 2402-2411
-
-
Esposito, K.1
Chiodini, P.2
Colao, A.3
-
86
-
-
79952072918
-
Metabolic syndrome and its association with colorectal cancer: A review
-
Siddiqui AA. Metabolic syndrome and its association with colorectal cancer: A review. Am J Med Sci 2011;341:227-31
-
(2011)
Am J Med Sci
, vol.341
, pp. 227-231
-
-
Siddiqui, A.A.1
-
87
-
-
84864184031
-
Growth signals, inflammation, and vascular perturbations: Mechanistic links between obesity, metabolic syndrome, and cancer
-
Hursting SD, Hursting MJ. Growth signals, inflammation, and vascular perturbations: Mechanistic links between obesity, metabolic syndrome, and cancer. Arterioscler Thromb Vasc Biol 2012; 32:1766-70
-
(2012)
Arterioscler Thromb Vasc Biol
, vol.32
, pp. 1766-1770
-
-
Hursting, S.D.1
Hursting, M.J.2
-
88
-
-
84866331749
-
Diabetes, body mass index, and outcomes in hepatocellular carcinoma patients undergoing liver transplantation
-
Siegel AB, Lim EA, Wang S, et al. Diabetes, body mass index, and outcomes in hepatocellular carcinoma patients undergoing liver transplantation. Transplantation 2012;94:539-43
-
(2012)
Transplantation
, vol.94
, pp. 539-543
-
-
Siegel, A.B.1
Lim, E.A.2
Wang, S.3
-
89
-
-
34547092697
-
Bile acid-induced TGR5-dependent c-Jun-N terminal kinase activation leads to enhanced caspase 8 activation in hepatocytes
-
Yang JI, Yoon JH, Myung SJ, et al. Bile acid-induced TGR5-dependent c-Jun-N terminal kinase activation leads to enhanced caspase 8 activation in hepatocytes. Biochem Biophys Res Commun 2007;361:156-61
-
(2007)
Biochem Biophys Res Commun
, vol.361
, pp. 156-161
-
-
Yang, J.I.1
Yoon, J.H.2
Myung, S.J.3
-
90
-
-
84873294643
-
The deficiency of G-proteincoupled bile acid receptor gpbar1 (TGR5) enhances chemicallyinduced liver carcinogenesis
-
Chen WD, Yu D, Forman BM, et al. The deficiency of G-proteincoupled bile acid receptor gpbar1 (TGR5) enhances chemicallyinduced liver carcinogenesis. Hepatology 2013;57:656-66
-
(2013)
Hepatology
, vol.57
, pp. 656-666
-
-
Chen, W.D.1
Yu, D.2
Forman, B.M.3
-
91
-
-
58649119388
-
Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment
-
Kortylewski M, Xin H, Kujawski M, et al. Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment. Cancer Cell 2009;15:114-23
-
(2009)
Cancer Cell
, vol.15
, pp. 114-123
-
-
Kortylewski, M.1
Xin, H.2
Kujawski, M.3
-
92
-
-
84862798695
-
Crosstalk of Sp1 and Stat3 signaling in pancreatic cancer pathogenesis
-
Huang C, Xie K. Crosstalk of Sp1 and Stat3 signaling in pancreatic cancer pathogenesis. Cytokine Growth Factor Rev 2012;23:25-35
-
(2012)
Cytokine Growth Factor Rev
, vol.23
, pp. 25-35
-
-
Huang, C.1
Xie, K.2
-
93
-
-
0036208350
-
Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line
-
Yoon JH, Higuchi H, Werneburg NW, et al. Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line. Gastroenterology 2002;122:985-93
-
(2002)
Gastroenterology
, vol.122
, pp. 985-993
-
-
Yoon, J.H.1
Higuchi, H.2
Werneburg, N.W.3
-
94
-
-
33846345695
-
Involvement of membrane-Type bile acid receptor M-BAR/TGR5 in bile acid-induced activation of epidermal growth factor receptor and mitogen-Activated protein kinases in gastric carcinoma cells
-
Yasuda H, Hirata S, Inoue K, et al. Involvement of membrane-Type bile acid receptor M-BAR/TGR5 in bile acid-induced activation of epidermal growth factor receptor and mitogen-Activated protein kinases in gastric carcinoma cells. Biochem Biophys Res Commun 2007;354:154-9
-
(2007)
Biochem Biophys Res Commun
, vol.354
, pp. 154-159
-
-
Yasuda, H.1
Hirata, S.2
Inoue, K.3
-
95
-
-
84865828003
-
The role of bile acids in the neoplastic progression of Barrett0s esophagus-A short representative overview
-
Jürgens S, Meyer F, Spechler SJ, Souza R. The role of bile acids in the neoplastic progression of Barrett0s esophagus-A short representative overview. Z Gastroenterol 2012;50:1028-34
-
(2012)
Z Gastroenterol
, vol.50
, pp. 1028-1034
-
-
Jürgens, S.1
Meyer, F.2
Spechler, S.J.3
Souza, R.4
-
96
-
-
77149120776
-
Role of a novel bile acid receptor TGR5 in the development of oesophageal adenocarcinoma
-
Hong J, Behar J, Wands J, et al. Role of a novel bile acid receptor TGR5 in the development of oesophageal adenocarcinoma. Gut 2010;59:170-80
-
(2010)
Gut
, vol.59
, pp. 170-180
-
-
Hong, J.1
Behar, J.2
Wands, J.3
-
97
-
-
84864383668
-
Chenodeoxycholic acid through a TGR5-dependent CREB signaling activation enhances cyclin D1 expression and promotes human endometrial cancer cell proliferation
-
Casaburi I, Avena P, Lanzino M, et al. Chenodeoxycholic acid through a TGR5-dependent CREB signaling activation enhances cyclin D1 expression and promotes human endometrial cancer cell proliferation. Cell Cycle 2012;11: 2699-710
-
(2012)
Cell Cycle
, vol.11
, pp. 2699-2710
-
-
Casaburi, I.1
Avena, P.2
Lanzino, M.3
-
98
-
-
34548611093
-
Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaea
-
Sato H, Genet C, Strehle A, et al. Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaea. Biochem Biophys Res Commun 2007;362:793-8
-
(2007)
Biochem Biophys Res Commun
, vol.362
, pp. 793-798
-
-
Sato, H.1
Genet, C.2
Strehle, A.3
-
99
-
-
74849119709
-
Structure-Activity relationship study of betulinic acid, a novel and selective TGR5 agonist, and its synthetic derivatives: Potential impact in diabetes
-
Genet C, Strehle A, Schmidt C, et al. Structure-Activity relationship study of betulinic acid, a novel and selective TGR5 agonist, and its synthetic derivatives: Potential impact in diabetes. J Med Chem 2010;53:178-90
-
(2010)
J Med Chem
, vol.53
, pp. 178-190
-
-
Genet, C.1
Strehle, A.2
Schmidt, C.3
-
100
-
-
73249142867
-
Discovery of 6alpha-ethyl-23(S)-methylcholic acid (S-EMCA, INT-777) as a potent and selective agonist for the TGR5 receptor, a novel target for diabesity
-
Pellicciari R, Gioiello A, Macchiarulo A, et al. Discovery of 6alpha-ethyl-23(S)-methylcholic acid (S-EMCA, INT-777) as a potent and selective agonist for the TGR5 receptor, a novel target for diabesity. J Med Chem 2009;52: 7958-61
-
(2009)
J Med Chem
, vol.52
, pp. 7958-7961
-
-
Pellicciari, R.1
Gioiello, A.2
Macchiarulo, A.3
-
101
-
-
73249134773
-
Discovery of 3-Aryl-4-isoxazolecarboxamides as TGR5 receptor agonists
-
Evans KA, Budzik BW, Ross SA, et al. Discovery of 3-Aryl-4- isoxazolecarboxamides as TGR5 receptor agonists. J Med Chem 2009;52:7962-5
-
(2009)
J Med Chem
, vol.52
, pp. 7962-7965
-
-
Evans, K.A.1
Budzik, B.W.2
Ross, S.A.3
-
102
-
-
75149187435
-
Biliary acute pancreatitis in mice is mediated by the G-protein-coupled cell surface bile acid receptor Gpbar1
-
Perides G, Laukkarinen JM, Vassileva G, Steer ML Biliary acute pancreatitis in mice is mediated by the G-protein-coupled cell surface bile acid receptor Gpbar1. Gastroenterology 2010;138: 715-25
-
(2010)
Gastroenterology
, vol.138
, pp. 715-725
-
-
Perides, G.1
Laukkarinen, J.M.2
Vassileva, G.3
Steer, M.L.4
-
103
-
-
84875034795
-
Pleiotropic functions of bile acids mediated by the farnesoid X receptor
-
Stanimirov B, Stankov K, Mikov M. Pleiotropic functions of bile acids mediated by the farnesoid X receptor. Acta Gastroenterol Belg 2012;75:389-98
-
(2012)
Acta Gastroenterol Belg
, vol.75
, pp. 389-398
-
-
Stanimirov, B.1
Stankov, K.2
Mikov, M.3
-
104
-
-
84857771313
-
Non-systemic drugs: A critical review
-
Charmot D. Non-systemic drugs: A critical review. Curr Pharm Des 2012;18:1434-45
-
(2012)
Curr Pharm Des
, vol.18
, pp. 1434-1445
-
-
Charmot, D.1
-
105
-
-
84880893548
-
Bile acid sequestration normalizes plasma cholesterol and reduces atherosclerosis in hypercholesterolemic mice No additional effect of physical activity
-
Meissner M, Wolters H, de Boer RA, et al. Bile acid sequestration normalizes plasma cholesterol and reduces atherosclerosis in hypercholesterolemic mice. No additional effect of physical activity. Atherosclerosis 2013;27:964-77
-
(2013)
Atherosclerosis
, vol.27
, pp. 964-977
-
-
Meissner, M.1
Wolters, H.2
De Boer, R.A.3
-
106
-
-
79959785811
-
Role of bile acid sequestrants in the treatment of type 2 diabetes
-
Handelsman Y. Role of bile acid sequestrants in the treatment of type 2 diabetes. Diabetes Care 2011;34:S244-50
-
(2011)
Diabetes Care
, vol.34
-
-
Handelsman, Y.1
-
107
-
-
84874184400
-
A review of the efficacy and safety of oral antidiabetic drugs
-
Stein SA, Lamos EM, Davis SN. A review of the efficacy and safety of oral antidiabetic drugs. Expert Opin Drug Saf 2013;12: 153-75
-
(2013)
Expert Opin Drug Saf
, vol.12
, pp. 153-175
-
-
Stein, S.A.1
Lamos, E.M.2
Davis, S.N.3
-
108
-
-
82555189369
-
Potential new approaches to modifying intestinal GLP-1 secretion in patients with type 2 diabetes mellitus: Focus on bile acid sequestrants
-
Holst JJ, McGill MA. Potential new approaches to modifying intestinal GLP-1 secretion in patients with type 2 diabetes mellitus: Focus on bile acid sequestrants. Clin Drug Investig 2012;32:1-14
-
(2012)
Clin Drug Investig
, vol.32
, pp. 1-14
-
-
Holst, J.J.1
McGill, M.A.2
-
109
-
-
84867574634
-
Review article: The emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-Alcoholic fatty liver disease
-
Zarrinpar A, Loomba R. Review article: The emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-Alcoholic fatty liver disease. Aiment Pharmacol Ther 2012;36:909-21
-
(2012)
Aiment Pharmacol Ther
, vol.36
, pp. 909-921
-
-
Zarrinpar, A.1
Loomba, R.2
-
110
-
-
84874031840
-
Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice
-
Potthoff MJ, Potts A, He T, et al. Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice. Am J Physiol Gastrointest Liver Physiol. 2013;304: G371-80
-
(2013)
Am J Physiol Gastrointest Liver Physiol
, vol.304
-
-
Potthoff, M.J.1
Potts, A.2
He, T.3
|